• Je něco špatně v tomto záznamu ?

Predictors of anastomotic leak and conduit necrosis after oesophagectomy: Results from the oesophago-gastric anastomosis audit (OGAA)

EA. Griffiths, Oesophago-Gastric Anastomotic Audit (OGAA) Collaborative, Writing Committee, Data Analysis, Steering Committee, National Leads, Site Leads, Collaborators

. 2024 ; 50 (6) : 107983. [pub] 20240307

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, multicentrická studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc24013701

BACKGROUND: Both anastomotic leak (AL) and conduit necrosis (CN) after oesophagectomy are associated with high morbidity and mortality. Therefore, the identification of preoperative, modifiable risk factors is desirable. The aim of this study was to generate a risk scoring model for AL and CN after oesophagectomy. METHODS: Patients undergoing curative resection for oesophageal cancer were identified from the international Oesophagogastric Anastomosis Audit (OGAA) from April 2018-December 2018. Definitions for AL and CN were those set out by the Oesophageal Complications Consensus Group. Univariate and multivariate analyses were performed to identify risk factors for both AL and CN. A risk score was then produced for both AL and CN using the derivation set, then internally validated using the validation set. RESULTS: This study included 2247 oesophagectomies across 137 hospitals in 41 countries. The AL rate was 14.2% and CN rate was 2.7%. Preoperative factors that were independent predictors of AL were cardiovascular comorbidity and chronic obstructive pulmonary disease. The risk scoring model showed insufficient predictive ability in internal validation (area under the receiver-operating-characteristic curve [AUROC] = 0.618). Preoperative factors that were independent predictors of CN were: body mass index, Eastern Cooperative Oncology Group performance status, previous myocardial infarction and smoking history. These were converted into a risk-scoring model and internally validated using the validation set with an AUROC of 0.775. CONCLUSION: Despite a large dataset, AL proves difficult to predict using preoperative factors. The risk-scoring model for CN provides an internally validated tool to estimate a patient's risk preoperatively.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24013701
003      
CZ-PrNML
005      
20240905133809.0
007      
ta
008      
240725s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ejso.2024.107983 $2 doi
035    __
$a (PubMed)38613995
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Griffiths, Ewen A $u Department of Upper Gastrointestinal Surgery, Queen Elizabeth Hospital Birmingham, Birmingham, UK. Electronic address: ewen.griffiths@uhb.nhs.uk
245    10
$a Predictors of anastomotic leak and conduit necrosis after oesophagectomy: Results from the oesophago-gastric anastomosis audit (OGAA) / $c EA. Griffiths, Oesophago-Gastric Anastomotic Audit (OGAA) Collaborative, Writing Committee, Data Analysis, Steering Committee, National Leads, Site Leads, Collaborators
520    9_
$a BACKGROUND: Both anastomotic leak (AL) and conduit necrosis (CN) after oesophagectomy are associated with high morbidity and mortality. Therefore, the identification of preoperative, modifiable risk factors is desirable. The aim of this study was to generate a risk scoring model for AL and CN after oesophagectomy. METHODS: Patients undergoing curative resection for oesophageal cancer were identified from the international Oesophagogastric Anastomosis Audit (OGAA) from April 2018-December 2018. Definitions for AL and CN were those set out by the Oesophageal Complications Consensus Group. Univariate and multivariate analyses were performed to identify risk factors for both AL and CN. A risk score was then produced for both AL and CN using the derivation set, then internally validated using the validation set. RESULTS: This study included 2247 oesophagectomies across 137 hospitals in 41 countries. The AL rate was 14.2% and CN rate was 2.7%. Preoperative factors that were independent predictors of AL were cardiovascular comorbidity and chronic obstructive pulmonary disease. The risk scoring model showed insufficient predictive ability in internal validation (area under the receiver-operating-characteristic curve [AUROC] = 0.618). Preoperative factors that were independent predictors of CN were: body mass index, Eastern Cooperative Oncology Group performance status, previous myocardial infarction and smoking history. These were converted into a risk-scoring model and internally validated using the validation set with an AUROC of 0.775. CONCLUSION: Despite a large dataset, AL proves difficult to predict using preoperative factors. The risk-scoring model for CN provides an internally validated tool to estimate a patient's risk preoperatively.
650    _2
$a lidé $7 D006801
650    12
$a ezofagektomie $7 D016629
650    12
$a netěsnost anastomózy $x epidemiologie $x etiologie $7 D057868
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    12
$a nádory jícnu $x chirurgie $x patologie $7 D004938
650    _2
$a senioři $7 D000368
650    _2
$a lidé středního věku $7 D008875
650    12
$a nekróza $7 D009336
650    _2
$a rizikové faktory $7 D012307
650    12
$a anastomóza chirurgická $7 D000714
650    _2
$a hodnocení rizik $7 D018570
650    _2
$a žaludek $x chirurgie $x patologie $7 D013270
650    _2
$a ROC křivka $7 D012372
650    _2
$a chronická obstrukční plicní nemoc $7 D029424
650    _2
$a index tělesné hmotnosti $7 D015992
650    _2
$a ezofágus $x chirurgie $x patologie $7 D004947
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
710    2_
$a Oesophago-Gastric Anastomotic Audit (OGAA) Collaborative
710    2_
$a Writing Committee
710    2_
$a Data Analysis
710    2_
$a Steering Committee
710    2_
$a National Leads
710    2_
$a Site Leads
710    2_
$a Collaborators
773    0_
$w MED00005360 $t European journal of surgical oncology $x 1532-2157 $g Roč. 50, č. 6 (2024), s. 107983
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38613995 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240725 $b ABA008
991    __
$a 20240905133803 $b ABA008
999    __
$a ok $b bmc $g 2143476 $s 1225567
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 50 $c 6 $d 107983 $e 20240307 $i 1532-2157 $m European journal of surgical oncology $n Eur J Surg Oncol $x MED00005360
LZP    __
$a Pubmed-20240725

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...